Ecolab Inc.

Ecolab reported Q3 organic sales growth of 7%, organic operating income growth of 11%, and organic operating margin of 19.6%. Management said organic gross margin was maintained despite significant commodity cost inflation. On a pro forma basis, including CoolIT and Ovivo, Q3 sales would have grown high single digits and adjusted EPS would have grown mid-teens. For Q4, Scott Kirkland said CoolIT-related amortization and interest were about a 12% drag, versus about a 10% headwind in Q3. Looking ahead to 2027, Ecolab expects organic sales growth at the upper end of its 5% to 7% target, adjusted operating margin to reach 20%, and adjusted EPS growth to accelerate in the second half as M&A transaction impacts roll off; management also reiterated a path to meet or exceed its 12% to 15% long-term adjusted EPS growth target.

Christophe Beck framed Q3 as an inflection point and said the One Ecolab strategy is driving better customer penetration, stronger growth, and broader outperformance versus end markets. He emphasized that the company is building faster-growth engines in Life Sciences, Digital, Pest, and Global High-Tech, while also reinforcing the core through pricing, service, and supply-chain execution. His tone was confident and upbeat, but he also said he was not satisfied with Institutional performance and wants the company to outgrow its markets by a wider margin.

Scott Kirkland focused on the financial bridge from Q3 into Q4 and 2027, highlighting the earnings drag from recent M&A. He said CoolIT-related amortization and interest were about a 10% EPS headwind in Q3 and should be about 12% in Q4, with 2027 modeled as roughly a 5-point first-half headwind and 5-point second-half tailwind from transaction and amortization effects. He also said Life Sciences margins remain strong, but Q4 should be in the mid- to high-teens range as the business continues to invest, even though the longer-term margin goal remains 30%.

Analysts pressed management on the sharp acceleration in High-Tech, asking whether it was driven by liquid cooling adoption, integration benefits, or unusual quarter timing. Beck said there has been little cross-selling yet, and the Q3 spike was mainly from strong demand, improved relevance of Ecolab’s technologies, and the shift toward direct-to-chip cooling rather than integration synergies. Questions also focused on pricing, margin durability, CoolIT visibility, and capital allocation; management said pricing stays elevated at about 5% to 6% for now, margins can be managed despite high DPC inflation, CoolIT is ahead of plan but still early, and deleveraging is the priority over new M&A.